Genetic/familial high-risk assessment: breast and ovarian

J Natl Compr Canc Netw. 2010 May;8(5):562-94. doi: 10.6004/jnccn.2010.0043.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • BRCA1 Protein / genetics
  • BRCA2 Protein / genetics
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / therapy
  • Breast Self-Examination
  • Female
  • Genetic Counseling
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Hamartoma Syndrome, Multiple / genetics
  • Humans
  • Li-Fraumeni Syndrome / genetics
  • Ovarian Neoplasms / diagnosis
  • Ovarian Neoplasms / epidemiology
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / therapy
  • Risk Assessment / methods
  • United States / epidemiology

Substances

  • BRCA1 Protein
  • BRCA2 Protein